Effect of telemedicine on diabetic treatment and complications

Hamed Saeed Al-Ghamdi, Abdelrahman Abdrabou Eldabbari, Salma Awadh Alharthi, Shahad Abdulbasit Alhutami, Mohammed Omar Aljiffry, Sultana Saadaldeen Alsharif, Ahmad Maeesh Alqurashi, Saeed Abdulsattar Mohammed, Maram Adnan Rawah, Mona Saleh Almalki, Taghreed Jaman Alotaibi


Investigations have also reported that the efficacy of telemedicine in the easy delivery of information and provision of regular patient-doctor interaction and therefore, enhancing the quality of care of diabetics and reducing the risk of developing severe complications. In the present study, we aimed to discuss telemedicine use in the management of diabetic complications, depending on information from studies within the literature. Overall, telemedicine assists patients to properly maintain basic and adequate levels of blood glucose levels through continuous reminders. Therefore, the application of this modality requires patients to have home-based assessment devices for the regular monitoring of the blood glucose levels. Moreover, the modality also enhances the connection between the patient and the physicians which make the patient at an ease of being able to communicate with the doctor whenever necessary and therefore, this might have a positive psychological impact on these patients. Moreover, telemedicine can provide patients with adequate treatment schedules that might help patients comply with their drugs. Additionally, it can provide the most appropriate dietary components that can also help in achieving the best intervention, with the necessary supervision. Although there is good evidence about the efficacy of telemedicine as an efficacious modality in the treatment of diabetes and management of complications, the evident application in the healthcare settings is still poor. The main reason behind such lack of proper application is the potential lack of adequate financial support, lack of experienced staff dealing with the modalities and maintaining the best quality of care for the patients.


Diabetes, Telemedicine, Care, Management, Complications

Full Text:



Ogurtsova K, Fernandes JDDR, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50.

Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(1):62-9.

Sasaki A, Horiuchi N, Hasegawa K, Uehara M. Mortality and causes of death in type 2 diabetic patients: a long-term follow-up study in Osaka district, Japan. Diabetes Res Clin Pract. 1989;7(1):33-40.

Zhu X, Zhang Y, Bai L, Zhang X, Zhou J, Yang J. Prediction of risk of diabetic retinopathy for all-cause mortality, stroke and heart failure. Medicine. 2017;96(3):5894.

Asfandiyarova NS. Risk factors of death in diabetes mellitus. Klinicheskaia Meditsina. 2016;94(9):697-700.

Craig J, Petterson V. Introduction to the practice of telemedicine. J Telemed Telecare. 2005;11(1):3-9.

Balkhi AM, Reid AM, Westen SC, Olsen B, Janicke DM, Geffken GR. Telehealth interventions to reduce management complications in type 1 diabetes: a review. World J Diabetes. 2015;6(3):371-9.

Omboni S, Caserini M, Coronetti C. Telemedicine and M-Health in hypertension management: technologies, applications and clinical evidence. High Blood Press Cardiovasc Prev. 2016;23(3):187-96.

Caldarola P, Gulizia MM, Gabrielli D, Sicuro M, Gennaro LD, Giammaria M, et al. ANMCO/SIT Consensus Document: telemedicine for cardiovascular emergency networks. European Heart J Suppl. 2017;19:229-43.

Eberly LA, Khatana SAM, Nathan AS, Snider C, Julien HM, Deleener ME, et al. Telemedicine outpatient cardiovascular care during the COVID-19 pandemic: bridging or opening the digital divide? Circulation. 2020;142(5):510-2.

Ahring KK, Ahring JPK, Joyce C, Farid NR. Telephone modem access improves diabetes control in those with insulin-requiring diabetes. Diabetes Care. 1992;15(8):971-5.

Bergenstal RM, Anderson RL, Bina DM, Johnson ML, Davidson JL, Solarz-Johnson B, et al. Impact of modem-transferred blood glucose data on clinician work efficiency and patient glycemic control. Diabetes Technol Ther. 2005;7(2):241-7.

Farmer A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med. 2005;22(10):1372-8.

Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011;28(4):455-63.

Heidgerken AD, Merlo L, Williams LB, Lewin AB, Gelfand K,

Murphy HR, Rayman G, Skinner TC. Psycho-educational interventions for children and young people with Type 1 diabetes. Diabet Med. 2006;23(9):935-43.

Borus JS, Laffel L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22(4):405-11.

Knight K, Bundy C, Morris R, Higgs JF, Jameson RA, Unsworth P, et al. The effects of group motivational interviewing and externalizing conversations for adolescents with Type-1 diabetes. Psychol Heal Med. 2003;8(2):149-57.

Wysocki T, Harris MA, Buckloh LM, Mertlich D, Lochrie AS, Taylor A, et al. Effects of behavioral family systems therapy for diabetes on adolescents' family relationships, treatment adherence, and metabolic control. J Pediatr Psychol. 2006;31(9):928-38.

Wysocki T, Harris MA, Greco P, Bubb J, Danda CE, Harvey LM, et al. Randomized, controlled trial of behavior therapy for families of adolescents with insulin-dependent diabetes mellitus. J Pediatr Psychol. 2000;25(1):23-33.

Adolfsson P, Veijola R, Huot C, Hansen HD, Lademann JB, Phillip M. Safety and patient perception of an insulin pen with simple memory function for children and adolescents with type 1 diabetes-the REMIND study. Curr Med Res Opin. 2012;28(9):1455-63.

Korytkowski M, Bell D, Jacobsen C, Suwannasari R. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther. 2003;25(11):2836-48.

Griffin SJ. Lost to follow-up: the problem of defaulters from diabetes clinics. Diabet Med. 1998;(3):14-24.

Shore JH, Brooks E, Savin DM, Manson SM, Libby AM. An economic evaluation of telehealth data collection with rural populations. Psychiatr Serv. 2007;58(6):830-5.

Russell-Minda E, Jutai J, Speechley M, Bradley K, Chudyk A, Petrella R. Health technologies for monitoring and managing diabetes: a systematic review. J Diabetes Sci Technol. 2009;3(6):1460-71.

Currie CJ, Peyrot M, Morgan CL, Poole CD, Jenkins-Jones S, Rubin RR, et al. The impact of treatment non-compliance on mortality in people with type 1 diabetes. J Diabetes Complications. 2013;27(3):219-23.

Farmer A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med. 2005;22(10):1372-8.

Howe CJ, Jawad AF, Tuttle AK, Moser JT, Preis C, Buzby M, et al. Education and telephone case management for children with type 1 diabetes: a randomized controlled trial. J Pediatr Nurs. 2005;20(2):83-95.

Bin-Abbas B, Jabbari M, Al-Fares A, El-Dali A, Al-Orifi F. Effect of mobile phone short text messages on glycaemic control in children with type 1 diabetes. J Telemed Telecare. 2014;20(3):153-6.

Holtz B, Lauckner C. Diabetes management via mobile phones: a systematic review. Am Telemed Assoc. 2012;18(3):175-84.

Hauser ST, Jacobson AM, Lavori P, Wolfsdorf JI, Herskowitz RD, Milley JE, et al. Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: II. Immediate and long-term linkages with the family milieu. J Pediatr Psychol. 1990;15(4):527-42.

Cafazzo JA, Casselman M, Hamming N, Katzman DK, Palmert MR. Design of an mHealth app for the self-management of adolescent type 1 diabetes: a pilot study. J Med Inter Res. 2012;14(3):70.

Louch G, Dalkin S, Bodansky J, Conner M. An exploratory randomised controlled trial using short messaging service to facilitate insulin administration in young adults with type 1 diabetes. Psychol Health Med. 2013;18(2):166-74.

Daniilidou K, Triantafyllou P, Resta M, Dimitriadou M, Christoforidis A. Level of internet use among Greek adolescents with type 1 diabetes. Int J Adolesc Med Health. 2017;31(1).

Grey M, Whittemore R, Jeon S, Murphy K, Faulkner MS, Delamater A. Internet psycho-education programs improve outcomes in youth with type 1 diabetes. Diabetes Care. 2013;36(9):2475-82.

Mulvaney SA, Rothman RL, Wallston KA, Lybarger C, Dietrich MS. An internet-based program to improve self-management in adolescents with type 1 diabetes. Diabetes Care. 2010;33(3):602-4.

Shalitin S, Ben-Ari T, Yackobovitch-Gavan M, Tenenbaum A, Lebenthal Y, Vries LD, et al. Using the internet-based upload blood glucose monitoring and therapy management system in patients with type 1 diabetes. Acta Diabetol. 2014;51(2):247-56.

Toma T, Athanasiou T, Harling L, Darzi A, Ashrafian H. Online social networking services in the management of patients with diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. Diabetes Res Clin Pract. 2014;106(2):200-11.

Azar M, Gabbay R. Web-based management of diabetes through glucose uploads: has the time come for telemedicine? Diabetes Res Clin Pract. 2009;83(1):9-17.

Ralston JD, Hirsch IB, Hoath J, Mullen M, Cheadle A, Goldberg HI. Web-based collaborative care for type 2 diabetes: a pilot randomized trial. Diabetes Care. 2009;32(2):234-9.

Izquierdo R, Morin PC, Bratt K, Moreau Z, Meyer S, Ploutz-Snyder R, et al. School-centered telemedicine for children with type 1 diabetes mellitus. J Pediatr. 2009;155(3):374-9.

Hanauer DA, Wentzell K, Laffel N, Laffel LM. Computerized automated reminder diabetes system (CARDS): e-mail and SMS cell phone text messaging reminders to support diabetes management. Diabetes Technol Ther. 2009;11(2):99-106.

Borries T, Dunbar A, Bhukhen A, Rismany J, Kilham J, Feinn R, et al. The impact of telemedicine on patient self-management processes and clinical outcomes for patients with Types I or II diabetes mellitus in the United States: a scoping review. Diabetes Metab Syndr. 2019;13(2):1353-7.

Soares NS, Langkamp DL. Telehealth in developmental-behavioral pediatrics. J Development Behavior Pediatr. 2012;33(8):656-65.

Whitten P, Buis L. Private payer reimbursement for telemedicine services in the United States. Am Telemed Assoc. 2007;13(1):15-23.

Guljas R, Ahmed A, Chang K, Whitlock A. Impact of telemedicine in managing type 1 diabetes among school-age children and adolescents: an integrative review. J Pediatr Nurs. 2014;29(3):198-204.